Bio-Rad Laboratories Inc $ 342.64 5.04 (1.49%)
On watch
Volume:
24,702
Avg Vol (1m):
215,859
Market Cap $:
10.06 Bil
Enterprise Value $:
9.74 Bil
P/E (TTM):
11.42
P/B:
1.86
| Earnings Power Value | ||
| Net Current Asset Value | ||
| Tangible Book | ||
| Projected FCF | ||
| Median P/S Value | ||
| Graham Number | ||
| Peter Lynch Value | ||
| DCF (FCF Based) | ||
| DCF (Earnings Based) | ||
|
Price: $342.64 | ||
Manual of Stocks™ Web
Financial Strength | 7/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | 1.49 | ||
| Equity-to-Asset | 0.72 | ||
| Debt-to-Equity | 0.12 | ||
| Debt-to-EBITDA | 0.48 | ||
| Interest Coverage | 8.94 | ||
| Piotroski F-Score | 4 | ||
| Altman Z-Score | 4.77 | ||
| Beneish M-Score | -2.77 | ||
| WACC vs ROIC | |||
Profitability | 7/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | 9.38 | ||
| Net Margin % | 39.54 | ||
| ROE % | 18.92 | ||
| ROA % | 13.62 | ||
| ROC (Joel Greenblatt) % | 93.64 | ||
| 3-Year Revenue Growth Rate | 3.3 | ||
| 3-Year EBITDA Growth Rate | 29.9 | ||
| 3-Year EPS without NRI Growth Rate | 48.3 |
Ratios |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| PE Ratio | 11.42 | ||
| PE Ratio without NRI | 11.42 | ||
| Price-to-Owner-Earnings | 8.17 | ||
| PB Ratio | 1.86 | ||
| PS Ratio | 4.45 | ||
| Price-to-Free-Cash-Flow | 41.8 | ||
| Price-to-Operating-Cash-Flow | 27.84 | ||
| EV-to-EBIT | 7.88 | ||
| EV-to-EBITDA | 7.02 | ||
| EV-to-Revenue | 4.23 | ||
| PEG Ratio | 1.42 | ||
| Shiller PE Ratio | 33.49 | ||
| Current Ratio | 4.68 | ||
| Quick Ratio | 3.36 | ||
| Days Inventory | 205.6 | ||
| Days Sales Outstanding | 60.27 | ||
| Days Payable | 85.81 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.8 |
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Tangible-Book | 1.99 | ||
| Price-to-Intrinsic-Value-Projected-FCF | 1.87 | ||
| Price-to-Intrinsic-Value-DCF (Earnings Based) | 1.07 | ||
| Price-to-Median-PS-Value | 2.65 | ||
| Price-to-Peter-Lynch-Fair-Value | 0.46 | ||
| Price-to-Graham-Number | 1 | ||
| Earnings Yield (Greenblatt) % | 12.68 | ||
| Forward Rate of Return (Yacktman) % | 21.06 |